ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Prevent Or Reverse Diabetes: An Amazing Herbal Intervention

Exercise and Vitamin D Better Together for Heart Health

VIDEO: Essential Oils for Weight Loss

Can Ginkgo Give Your Brain a Boost?

Can Valerian Root Help You Sleep Better?

Fighting Statin-Induced Diabetes with CoQ10

Eight servings of veggies a day is clearly best for the heart

Curcumin — A Novel Treatment Alternative for Depression

How Glycation Accelerates Aging

Zinc acetate lozenges may increase the recovery rate from the common cold by three-fold

 
Print Page
Email Article

First Report of Stem Cell Signal of Intention to Become Specific Neuron; Cloned Cells Cure Parkinson’s in Rat Model

  [ 51 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 9, 2002





Scientists at Rush-Presbyterian-St. Luke's Medical Center in Chicago have discovered an important shortcut to creating a more efficient, more reliable, and safer source of stem cells with the ability to turn into specific neurons or brain cells. Paul Carvey, PhD, chairman of pharmacology at Rush, used his team's discovery to clone several generations of stem cells that, when grafted into the brains of rats with a Parkinson's like disease, developed into healthy dopamine neurons. This effectively cured the animals' severe Parkinsonian symptoms.

The ability to clone large numbers of stem cells that would become neurons also has the potential to revolutionize the treatment of Alzheimer's disease, multiple sclerosis and numerous other diseases and disorders of the brain and nervous system.

The findings, and their clinical significance, were presented at the Experimental Biology 2002 meetings in New Orleans last month.

This study is the first to identify the signal that instructs stem/progenitor cells to become dopamine neurons, the cells that degenerate in the brain of patients with Parkinson's disease.

The research team found that the primary signal responsible for determining that a progenitor cell will become a neuron is Interleukin 1, a member of the general class of molecules called cytokines, which are responsible for determining when blood stem cells differentiate into blood cells.

Being able to read the stem cells' intention enabled Carvey to select cells already committed to becoming neurons and to clone only those stem cells for transplantation. "We let the body do its own thing," he says. "We watched while it ran these stem cells down the lineage restriction pathways until the cells were almost neurons. Then we grabbed those cells, and only those cells, for our cloning activity."

Such specificity is important for two reasons, he adds. First, you want to produce large quantities of cells that will become the cells you need as quickly as possible. Second, you want to avoid including in your cloning process even one cell that has not yet firmly committed to becoming a neuron but will instead develop into a tumor or other troublesome cell once implanted.

Carvey said that many people do not always recognize the difference between the various types of stem cells. The defining hallmark of the different type of stem cells is not where they come from but how far along the lineage restriction pathway they are.

Many people confuse all types of stem cells with embryonic stem cells, which are taken from the earliest stages of an embryo, generally at 32 cells or less. Such cells have the potential to turn into dopamine neurons when implanted in the brains of humans with Parkinson's disease. Carvey's group did not want to work with this type cell, however, not because of the political difficulties but because it is only at the beginning of the lineage restriction pathway. There are basically three types of stem cells: embryonic stem cells which can become any cell in the body, stem cells for a specific organ that can become any cell in that particular organ (such as brain stem cells that can become any kind of brain cell), and then a more specialized group of stem cells called progenitor cells that are committed to becoming a certain type of cell, such as a dopamine neuron.

"Embryonic stem cells can literally develop into any cells," he said. "We wanted stem cells right at the point of becoming the cells we wanted and therefore unlikely to become cells we didn't want."

They also did not want to work with central nervous system (CNS) stem cells, one of the various types of stem cells taken from an organ and which already have committed to becoming very specific types of cells in that organ. These cells might turn into dopamine neurons but they also might turn into other types of neurons or into any of dozens of brain or nervous system cells. Carvey says it would take years to identify the different signals determining which of hundreds of possible routes the individual CNS stem cells would take. Instead, he and his team went as far down the lineage pathway as possible, right to the progenitor stem cells at the point of committing to a particular cells.

"These results are very encouraging," says Carvey, "because they are proof that it is possible to identify progenitor cells in well developed brains, stem cells that can be selected for the type of cell needed for clinical treatment, and cloned with very little chance of including cells you don't want. We took progenitor stem cells from the midbrain of a fetal rat, but many scientists believe it may be possible to find progenitor cells in adult brains using needle biopsy of living patients (a procedure already being done in humans for different reasons). Cells about to become the needed neurons would be selected, cloned, and placed back in the patient's brain, like an autograft. We know these cells have the capacity to develop into healthy neurons. If the results resembled those we found in our rats, this process could provide stunning new treatments for Parkinson's, Alzheimer's and other diseases.



Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® FibroSleep™ Energy NADH™ 12.5mg

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH
Why Berries Offer a Rainbow of Health Benefits Why Berries Offer a Rainbow of Health Benefits
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map